Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

374 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.
Baker GB, Coutts RT, McKenna KF, Sherry-McKenna RL. Baker GB, et al. J Psychiatry Neurosci. 1992 Nov;17(5):206-14. J Psychiatry Neurosci. 1992. PMID: 1362653 Free PMC article. Review.
Does hair zinc predict amphetamine improvement of ADD/hyperactivity?
Arnold LE, Votolato NA, Kleykamp D, Baker GB, Bornstein RA. Arnold LE, et al. Among authors: baker gb. Int J Neurosci. 1990 Jan;50(1-2):103-7. doi: 10.3109/00207459008987161. Int J Neurosci. 1990. PMID: 2269593
Human CYP2D6 and metabolism of m-chlorophenylpiperazine.
Rotzinger S, Fang J, Coutts RT, Baker GB. Rotzinger S, et al. Among authors: baker gb. Biol Psychiatry. 1998 Dec 1;44(11):1185-91. doi: 10.1016/s0006-3223(97)00483-6. Biol Psychiatry. 1998. PMID: 9836023
Effects of low- and high-dose tranylcypromine on [3H]tryptamine binding sites in the rat hippocampus and striatum.
Goodnough DB, Baker GB, Mousseau DD, Greenshaw AJ, Dewhurst WG. Goodnough DB, et al. Among authors: baker gb. Neurochem Res. 1994 Jan;19(1):5-8. doi: 10.1007/BF00966720. Neurochem Res. 1994. PMID: 8139763
Trace amines and Tourette's syndrome.
Baker GB, Bornstein RA, Yeragani VK. Baker GB, et al. Neurochem Res. 1993 Sep;18(9):951-6. doi: 10.1007/BF00966752. Neurochem Res. 1993. PMID: 8232722 Review.
4-Ethoxyamphetamine: effects on intracranial self-stimulation and in vitro uptake and release of 3H-dopamine and 3H-serotonin in the brains of rats.
Hegadoren KM, Greenshaw AJ, Baker GB, Martin-Iverson MT, Lodge B, Soin S. Hegadoren KM, et al. Among authors: baker gb. J Psychiatry Neurosci. 1994 Jan;19(1):57-62. J Psychiatry Neurosci. 1994. PMID: 8148367 Free PMC article.
Metabolism of monoamine oxidase inhibitors.
Baker GB, Coutts RT. Baker GB, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(3-4):395-403. doi: 10.1016/0278-5846(89)90128-0. Prog Neuropsychopharmacol Biol Psychiatry. 1989. PMID: 2664891 Review.
Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata.
Baker GB, Reynolds GP. Baker GB, et al. Neurosci Lett. 1989 May 22;100(1-3):335-9. doi: 10.1016/0304-3940(89)90709-x. Neurosci Lett. 1989. PMID: 2474777
Phenylethylaminergic mechanisms in attention-deficit disorder.
Baker GB, Bornstein RA, Rouget AC, Ashton SE, van Muyden JC, Coutts RT. Baker GB, et al. Biol Psychiatry. 1991 Jan 1;29(1):15-22. doi: 10.1016/0006-3223(91)90207-3. Biol Psychiatry. 1991. PMID: 2001444
Effects of low-dose 4-fluorotranylcypromine on rat brain monoamine oxidase and neurotransmitter amines.
Sherry RL, Baker GB, Coutts RT. Sherry RL, et al. Among authors: baker gb. Biol Psychiatry. 1990 Sep 15;28(6):539-43. doi: 10.1016/0006-3223(90)90491-j. Biol Psychiatry. 1990. PMID: 1699613 No abstract available.
374 results
Jump to page